AstraZeneca Sues Mylan Over Fresh Asthma Drug Patent
IP Law 360
APRIL 26, 2022
After AstraZeneca obtained a drug patent related to asthma treatment Symbicort on Tuesday, the biopharmaceutical company wasted no time filing a patent suit the same day against Mylan and drug delivery service Kindeva in West Virginia federal court over an abbreviated new-drug application.
40 
Let's personalize your content